PWS patients seem to be particularly sensitive to GH, as at standard doses they often present IGF-1 levels above the normal limits, in particular in individuals with PWS due to mUPD (128); special care must be taken in biochemical monitoring for a possible association between IGF-1 values and the occurrence of adverse effects (129–131). This evidence concerns the gene IGF1 and Prader-Willi syndrome.